For decades, scientists have believed that complex life began when two very different microbes joined forces, eventually ...
A giant virus discovered in Japan is adding fuel to the provocative idea that viruses helped create complex life. Named ushikuvirus, it infects amoebae and shows unique traits that connect different ...
Strategic catalysts for 2025 include the U.S. launch of SAPIEN M3 and the introduction of next-gen PASCAL in Q4, with a potential tailwind from an updated National Coverage Determination (NCD) for ...
With more than 15 years of experience, Simplicis delivers a data and workflow management platform designed to support complex experimental designs, including pooling, mixtures, and dynamic curve ...
A Dalai Lama once said that our prime purpose in this life is to help others – and he may have been right. Scientists have found that having a positive impact on other people seems to be a key element ...
European investment firm Gimv will no longer put funds into the life sciences sector, choosing instead to focus on its long-term investments and finding new value in four other key areas. The decision ...
BlueRidge Life Sciences (“BlueRidge”), a leading life sciences consulting and services platform and a portfolio company of Renovus Capital Partners, today announced the acquisition of Design Science, ...
Chiba, Japan, January 12, 2026—A team at Japan’s National Institutes for Quantum Science and Technology (QST) has published a field-defining Perspective that places the societal payoff of quantum ...
Life sciences mergers and acquisitions surged back in force in 2025, as pharmaceutical and med-tech companies moved aggressively to shore up pipelines and offset looming revenue losses, according to ...
Power Moves is a recurring series where we chart the comings and goings of talent across the region. Got a new hire, gig or promotion? Email us at philly@technical.ly. Philly companies and ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The developer behind ...
Over the past four years, private equity (PE) firms that invested in life science assets have faced a difficult reality. While many investors still debate whether some sectors of the market are in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results